BPFA
ARKG icon

Barnes Pettey Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Barnes Pettey Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,170
Closed -$363K – 101
2024
Q3 		$363K Sell
14,170
-1,209
-8% -$30.8K 0.29% 61
2024
Q2 		$361K Sell
15,379
-7,387
-32% -$186K 0.31% 57
2024
Q1 		$655K Sell
22,766
-1,633
-7% -$49.1K 0.57% 36
2023
Q4 		$801K Sell
24,399
-9,974
-29% -$271K 0.65% 34
2023
Q3 		$958K Sell
34,373
-1,086
-3% -$35.5K 0.88% 26
2023
Q2 		$1.21M Buy
35,459
+519
+1% +$16.3K 1.05% 24
2023
Q1 		$1.05M Buy
34,940
+409
+1% +$12.7K 1% 24
2022
Q4 		$975K Sell
34,531
-6,313
-15% -$200K 1.01% 25
2022
Q3 		$1.34M Buy
40,844
+3,183
+8% +$117K 1.83% 14
2022
Q2 		$1.19M Sell
37,661
-13,831
-27% -$484K 1.53% 17
2022
Q1 		$2.37M Sell
51,492
-3,786
-7% -$180K 2.86% 7
2021
Q4 		$3.38M Buy
+55,278
New +$3.82M 3.89% 4

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Barnes Pettey Financial Advisors's ARKG Position: Q4 2024 in Review

Barnes Pettey Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 14,170 shares — an estimated $363K sold.

Barnes Pettey Financial Advisors first reported a position in ARKG in Q4 2021 and held it in 12 quarters. The position peaked at $3.38M in Q4 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Barnes Pettey Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Barnes Pettey Financial Advisors sold 14,170 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $363K.
  • Barnes Pettey Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 12 quarters.
  • Barnes Pettey Financial Advisors's ARK Genomic Revolution ETF position peaked at $3.38M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Barnes Pettey Financial Advisors's 13F filing for Q4 2024, filed 23 Jan 2025.